Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Marvel Biosciences Corp (MRVL.VN)

Marvel Biosciences Corp (MRVL.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,979
  • Shares Outstanding, K 39,786
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,554 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.46
Trade MRVL.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.095 +15.79%
on 01/25/23
0.130 -15.38%
on 01/03/23
-0.015 (-12.00%)
since 12/30/22
3-Month
0.095 +15.79%
on 01/25/23
0.170 -35.29%
on 11/22/22
-0.005 (-4.35%)
since 10/25/22
52-Week
0.075 +46.67%
on 10/11/22
0.230 -52.17%
on 02/11/22
-0.060 (-35.29%)
since 01/28/22

Most Recent Stories

More News
Stocks in play: Marvel Biosciences Corp

Announces that it has successfully completed a multi-kilogram scale run under current good manufacturing ...

NXE.TO : 6.42 (-1.98%)
MRVL.VN : 0.110 (+10.00%)
Marvel Biosciences Completes a Critical Manufacturing Milestone Required to Enter Phase 1 Human Trials Targeting Alzheimer's Disease and Depression

Calgary, Alberta--(Newsfile Corp. - January 6, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company " or "Marvel "), are pleased...

MRVL.VN : 0.110 (+10.00%)
Stocks in play: Marvel Biosciences Corp

Announces it has successfully completed its dose-ranging toxicology studies in rats and dogs, for its ...

MRVL.VN : 0.110 (+10.00%)
Marvel Biosciences Successfully Completes its Short Term Dose Ranging Study in Rats and Dogs for MB-204

Calgary, Alberta--(Newsfile Corp. - January 3, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MRVL.VN : 0.110 (+10.00%)
Stocks in play: Marvel Biosciences Corp

Announced that its board of directors has approved the grant of incentive stock options to a director ...

MRVL.VN : 0.110 (+10.00%)
Stocks in play: Marvel Biosciences Corp

With its wholly owned subsidiary, Marvel Biotechnology Inc, announces it has initiated its 10-day, dose-ranging ...

MRVL.VN : 0.110 (+10.00%)
Stocks in play: Marvel Biosciences Corp

Announces, along with its wholly owned subsidiary Marvel Biotechnology Inc., that it has initiated its ...

MRVL.VN : 0.110 (+10.00%)
Stocks in play: Marvel Biosciences Corp

Announces that Mr. Babak Pedram has joined its Board of Directors. Mr. Pedram is a seasoned capital ...

MRVL.VN : 0.110 (+10.00%)
Canadian Micro Cap Gets Boost Following Study Findings

A Calgary-based %Biotech company is turning heads on Tuesday after it was announced that a recent study showed its lead drug candidate MB-204 demonstrated a 400% increase in the survival rate of animals...

MRVL.VN : 0.110 (+10.00%)
Stocks in play: Marvel Biosciences Corp

Announces that its lead drug candidate MB-204 demonstrated a 400% increase in the survival rate of animals ...

MRVL.VN : 0.110 (+10.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.117
2nd Resistance Point 0.113
1st Resistance Point 0.112
Last Price 0.110
1st Support Level 0.107
2nd Support Level 0.103
3rd Support Level 0.102

See More

52-Week High 0.230
Fibonacci 61.8% 0.171
Fibonacci 50% 0.153
Fibonacci 38.2% 0.134
Last Price 0.110
52-Week Low 0.075

See More

Business Summary

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known proven drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar